Suffolk Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.2M |
| 2 |
Apple
AAPL
|
+$14.2M |
| 3 |
T-Mobile US
TMUS
|
+$12.4M |
| 4 |
Biogen
BIIB
|
+$11.8M |
| 5 |
Kraft Heinz
KHC
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$13.5M |
| 2 |
IBM
IBM
|
+$12.9M |
| 3 |
AET
Aetna Inc
AET
|
+$12.1M |
| 4 |
MGM Resorts International
MGM
|
+$11.5M |
| 5 |
Prudential Financial
PRU
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.48% |
| 2 | Technology | 17.46% |
| 3 | Industrials | 14.34% |
| 4 | Consumer Discretionary | 12.95% |
| 5 | Communication Services | 12.48% |
Similar funds
Suffolk Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Suffolk Capital Management held 169 positions worth $726M, down 6.4% from $776M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Suffolk Capital Management withdrew a net $99.5M in Q3 2016, closing 35 positions and reducing 81 holdings. Its most notable exit was Humana, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Suffolk Capital Management opened a new position in IVERIC bio, Inc. Common Stock worth $11.6M.
- Suffolk Capital Management's largest Q3 2016 buy was IVERIC bio, Inc. Common Stock: 252,355 shares worth $11.6M.
- Suffolk Capital Management added most to Apple in Q3 2016, an estimated $14.2M increase.
- Suffolk Capital Management's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $8.8M.
- Suffolk Capital Management fully exited Humana in Q3 2016, selling an estimated $13.5M.
- Suffolk Capital Management's ten largest holdings make up 24% of its $726M portfolio in Q3 2016.
- Suffolk Capital Management opened 31 new positions and closed 35 in Q3 2016.
- Suffolk Capital Management's portfolio value fell 6.4% quarter-over-quarter to $726M.
Based on Suffolk Capital Management's 13F filing for Q3 2016, filed 31 Oct 2016.